Article
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.
Thyroid : official journal of the American Thyroid Association - 1 Aug 2014
Russo Marco, Malandrino Pasqualino, Nicolosi Maria Luisa, Manusia Mario, Marturano Ilenia, Trovato Maria Antonietta, Pellegriti Gabriella, Frasca Francesco, Vigneri Riccardo
Abstract excerpt
INTRODUCTION: The prognostic usefulness of BRAF(V600E) evaluation in papillary thyroid cancer (PTC) has been analyzed in many studies, with controversial conclusions. AIM: To analyze the clinical relevance of BRAF(V600E) measurement in a homogenous series of PTC patients followed in a single institution. METHODS: One hundred three classical variant PTC patients who underwent total thyroidectomy in the 3-year...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
